Drug Type Small molecule drug |
Synonyms 7-deaza-6-methyl-9-β-D-ribofuranosylpurine, compound 6(University of Kansas) |
Target- |
Action inhibitors |
Mechanism Virus replication inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H15N3O4 |
InChIKeyTWVNSMOKOGLVNT-DNRKLUKYSA-N |
CAS Registry1256159-09-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dengue | Preclinical | United States | 22 May 2010 | |
Poliomyelitis | Preclinical | United States | 22 May 2010 |